Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Author: Benzinga Insights | March 28, 2024 08:06am

Gainers

  • Avalo Therapeutics (NASDAQ:AVTX) shares rose 328.2% to $20.34 during Thursday's pre-market session. The company's market cap stands at $16.3 million.
  • Xilio Therapeutics (NASDAQ:XLO) stock moved upwards by 223.94% to $2.07. The market value of their outstanding shares is at $56.9 million.
  • Akanda (NASDAQ:AKAN) shares increased by 27.1% to $0.21. The company's market cap stands at $1.8 million.
  • Kintara Therapeutics (NASDAQ:KTRA) shares rose 23.01% to $0.11. The market value of their outstanding shares is at $4.2 million.
  • Akebia Therapeutics (NASDAQ:AKBA) stock increased by 18.34% to $2.65. The company's market cap stands at $555.0 million.
  • INVO Bioscience (NASDAQ:INVO) stock increased by 16.36% to $1.28. The company's market cap stands at $3.1 million.

Losers

  • NuCana (NASDAQ:NCNA) stock declined by 19.8% to $0.25 during Thursday's pre-market session. The market value of their outstanding shares is at $13.0 million.
  • Yield10 Bioscience (NASDAQ:YTEN) shares declined by 10.51% to $0.34. The company's market cap stands at $4.0 million.
  • Sonoma Pharmaceuticals (NASDAQ:SNOA) shares declined by 10.48% to $0.15. The market value of their outstanding shares is at $2.3 million.
  • PAVmed (NASDAQ:PAVM) stock fell 9.87% to $2.46. The market value of their outstanding shares is at $19.8 million. The company's, Q4 earnings came out 2 days ago.
  • YS Biopharma Co (NASDAQ:YS) shares decreased by 9.43% to $0.64. The market value of their outstanding shares is at $121.1 million.
  • Immuron (NASDAQ:IMRN) shares declined by 9.0% to $2.53. The company's market cap stands at $14.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AKAN AKBA AVTX IMRN INVO KTRA NCNA PAVM SNOA XLO YS YTEN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist